Trials / Conditions / Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphocytic Leukaemia (CLL)
6 registered clinical trials studyying Chronic Lymphocytic Leukaemia (CLL) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in NCT06821880 | Medical University Innsbruck | — |
| Enrolling By Invitation | Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR NCT06762431 | Vitebsk Regional Clinical Cancer Centre | Phase 1 / Phase 2 |
| Active Not Recruiting | Retention Rate of Acalabrutinib in a Non-interventional Setting NCT05645172 | AstraZeneca | — |
| Terminated | Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indole NCT02273856 | Astellas Pharma International B.V. | — |
| Completed | Dose-escalation Study of Oral Administration of S 55746 in Patients With Chronic Lymphocytic Leukaemia and B-C NCT02920697 | Institut de Recherches Internationales Servier | Phase 1 |
| Completed | CLL Empirical Antibiotic Regimen NCT01279252 | King's College Hospital NHS Trust | Phase 2 |